Position in XENE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$94,298,979
+$12,697,259 QoQ
Shares Held
1,562,276
+11.3% QoQ
Ownership
1.61%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#15
of 314 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ALLIANCEBERNSTEIN L.P. holds $5,177,847,011 across 257 Biotechnology names. XENE ranks #14 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,019,315 | $1,499,784,339 | |
| 2 | ARGX |
Argenx SE
|
395,661 | $367,082,405 | |
| 3 | GMAB |
Genmab A/S
|
8,644,877 | $237,474,771 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
292,338 | $182,284,436 | |
| 5 | TECH |
BIO-TECHNE Corp
|
2,002,026 | $141,443,136 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
1,696,538 | $132,788,029 | |
| 7 | KYMR |
Kymera Therapeutics, Inc.
|
981,521 | $112,551,013 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,453,504 | $108,256,977 |
All Filings in XENE
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $94,298,979 | 1,562,276 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $81,601,720 | 1,403,297 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $71,434,743 | 1,593,814 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $66,424,842 | 1,654,417 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $47,529,895 | 1,518,527 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $44,600,900 | 1,329,386 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $56,572,656 | 1,443,180 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $56,091,816 | 1,424,735 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $57,828,642 | 1,483,166 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $63,216,600 | 1,468,446 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $72,524,602 | 1,574,568 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $37,040,951 | 1,084,337 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,541,616 | 66,016 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $3,863,959 | 107,962 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,241,004 | 56,835 | Shares | Defined | 2023-02-15 | |
| 2022-09-30 | $5,152,408 | 142,726 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $13,079,383 | 429,960 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $11,514,221 | 376,651 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $9,187,621 | 294,098 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $4,020,213 | 263,103 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $370,686 | 19,908 | Shares | Defined | 2021-07-30 | |
| No filing history on record for this holder in this stock. | ||||||